bisindolylmaleimide i has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carey, JO | 1 |
| Posekany, KJ | 1 |
| deVente, JE | 1 |
| Pettit, GR | 1 |
| Ways, DK | 1 |
1 other study available for bisindolylmaleimide i and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Phorbol ester-stimulated phosphorylation of PU.1: association with leukemic cell growth inhibition.
Topics: Base Sequence; Bryostatins; Cell Differentiation; Cell Division; DNA, Neoplasm; Enhancer Elements, G | 1996 |